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Alzheimer’s disease (AD) is characterized by progressive cognitive decline and
neuropsychiatric symptoms. Increasing evidence indicates that environmental risk
factors in young adults may accelerate cognitive loss in AD and that Hydrogen Sulfide
(H2S) may represent an innovative treatment to slow the progression of AD. Therefore,
the aim of this study was to evaluate the effects of NaHS, an H2S donor, in a triple
transgenic AD mouse model (3×Tg-AD) under footshock with situational reminders
(SRs). Inescapable footshock with SRs induced anxiety and cognitive dysfunction as
well as a decrease in the levels of plasma H2S and GSH and an increase in IL-6 levels
in 3×Tg-AD mice. Under footshock with SR stimulus, amyloid deposition, tau protein
hyperphosphorylation, and microgliosis were highly increased in the stress-responsive
brain structures, including the hippocampus and amygdala, of the AD mice. Oxidative
stress, inflammatory response, and β-site APP cleaving enzyme 1 (BACE1) levels were
also increased, and the level of inactivated glycogen synthase kinase-3β (GSK3β)
(pSer9) was decreased in the hippocampi of AD mice subjected to footshock with SRs.
Furthermore, the numbers of cholinergic neurons in the medial septum/diagonal band
of Broca (MS/DB) and noradrenergic neurons in the locus coeruleus (LC) were also
decreased in the 3×Tg-AD mice under footshock with SRs. These biochemical hallmarks
and pathological presentations were all alleviated by the semi-acute administration of
NaHS in the AD mice. Together, these findings suggest that footshock with SRs induces
the impairment of spatial cognition and emotion, which involve pathological changes in
the peripheral and central systems, including the hippocampus, MS/DB, LC, and BLA,
and that the administration of NaHS may be a candidate strategy to ameliorate the
progression of neurodegeneration.
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INTRODUCTION
Alzheimer’s disease (AD) is characterized by neuropsychological symptoms such as anxiety,
depression and progressive cognitive deficits along with the deposition of extracellular plaques
composed of β-amyloid (Aβ) and intracellular neurofibrillary tangles (NFTs) composed of
hyperphosphorylated tau protein. A recent study suggests that psychiatric symptoms such as
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depression and anxiety increase the severity of cognitive deficits
(Ringman et al., 2015). Evidence also indicates that anxiety but
not depressive symptoms moderates the effect of Aβ burden
on the decline in verbal episodic memory of healthy older
adults without dementia (Pietrzak et al., 2014) and in the
early stages of AD (Hwang et al., 2004). Frequent or constant
stress has also been found to be positively associated with the
development of dementia, particularly in the early stages of
AD (Johansson et al., 2010; Hebda-Bauer et al., 2013). We
previously demonstrated that anxiety induced by inescapable
footshock stress associated with situational reminders (SRs)
enhances the toxicity of oligomeric Aβ40 and also increases
the severity of cognitive decline in C57BL/6J mice (Huang
et al., 2010). Chronic mild stress increases β-site APP cleaving
enzyme 1 (BACE1) levels in the hippocampus of aged mice
(O’Connor et al., 2008; Solas et al., 2013). Stress hormones such as
glucocorticoids may interfere with the balance between total and
phosphorylated tau (Liston and Gan, 2011). Treatment of triple
transgenic APP/PS1/tau (3×Tg-AD) mice with dexamethasone,
a glucocorticoid receptor agonist, increases brain Aβ levels
(Green et al., 2006). In pilot studies, we have demonstrated that
male 3×Tg-AD mice exhibit only a mild phenotype at 6 months
of age. Therefore, in this study, inescapable footshock with SRs
was used to accelerate disease progression in 6-month-old male
3×Tg-AD mice.
Over the last decade, numerous experimental and clinical
studies have demonstrated that Aβ plays an important
pathogenic role in AD (Lin et al., 2000; Strömberg et al.,
2015). Aβ peptides are generated from the sequential proteolytic
processing of amyloid precursor protein (APP) by β- and γ-
secretases (Strömberg et al., 2015). β-secretase was identified as
the transmembrane aspartic protease BACE1 and is responsible
for initiating the cleavage of APP (Lin et al., 2000). BACE1
levels and activity are increased in AD (Zhao et al., 2007; Cheng
et al., 2014). However, most clinical trials of anti-Aβ therapies
have produced little improvement in cognitive function
(Castellani and Smith, 2011). Therapeutic strategies that target
tau pathology may be more clinically effective than Aβ-directed
therapies (Giacobini and Gold, 2013), and very recent studies
have suggested that misfolded hyperphosphorylated tau proteins
play an important role in AD synaptic dysfunction (Tai et al.,
2012; Sokolow et al., 2014). Glycogen synthase kinase-3β
(GSK3β) is likely the predominant kinase catalyzing tau protein
hyperphosphorylation and subsequent generation of NFTs
in AD (Takashima, 2006). However, clinical assessments of
GSK3β inhibitors such as lithium or tideglusib have shown no
improvement in AD patients (Hampel et al., 2009; Lovestone
et al., 2015). Furthermore, long-term treatment with GSK3
inhibitors may be associated with target-related side effects
(Tell and Hilgeroth, 2013). These challenges have motivated the
development of alternative therapeutic strategies that target the
multiple pathogenic cascades of AD (Chen and Zhong, 2013).
Hydrogen sulfide (H2S) is an environmental toxin
that inhibits cytochrome oxidase (Complex IV) in the
mitochondria (Dorman et al., 2002). Three enzymes produce
H2S in mammalian tissue: cystathionine-b-synthase (CBS),
cystathionine-c-lyase (CSE) and 3-mercaptopyruvate sulfur
transferase (3MST). CBS is primarily expressed in the
central nervous system (Kimura, 2011). H2S also has anti-
neuroinflammatory (Hu et al., 2007), anti-apoptotic (Yin et al.,
2009), antioxidative stress and neuroprotective (Liu and Bian,
2010) effects in mammalian tissue. Endogenous H2S levels are
severely decreased in the brains of AD patients (Eto et al., 2002),
and plasmaH2S concentrations are negatively correlated with the
severity of AD (Liu et al., 2008). Taken together, these findings
suggest that H2S may protect the brain against footshock with
SRs stimulus in 3×Tg-AD mice. Therefore, we examined the
neuroprotective effects of NaHS treatment on 3×Tg-AD mice
stimulated with footshock with SRs.
MATERIALS AND METHODS
Animals
Pregnant C57BL/6J female mice and 3×Tg-AD (harboring the
PS1M146V, APPSwe and TauP30IL transgenes) mice were purchased
from the National Breeding Centre for Laboratory Animals and
Jackson Laboratory (004807). The phenotype of the male 3×Tg-
AD mice (6 months old) was exacerbated by one footshock
and four SRs. NaHS or vehicle (saline) was administered before
each footshock and SR. The mice were housed in individual
ventilation cages at 20–25◦C, with free access to food and water
and a 12/12-h light/dark cycle (7 AM to 7 PM). This study
was conducted in strict accordance with the recommendations
of the Guide for the Care and Use of Animals of the National
Laboratory Animal Center, Taiwan. The protocol was approved
by the Committee on the Ethics of Animal Experiments
of the National Taiwan Normal University (Permit Number:
102001).
Primary Cultures of Mouse Hippocampal
Neurons and Drug Treatments
The method used to prepare primary cell cultures was slightly
modified from a previously described protocol (Seibenhener
and Wooten, 2012). Briefly, pregnant C57BL/6J mice were
sacrificed by cervical dislocation, and the hippocampi were
dissected and removed from the brains of embryonic day 16–18
(E16–18) embryos. Tissues were trypsinized (0.05%) for 15 min
at 37◦C. The cells were plated on 24-well plates (3 × 104
cells per culture well) pre-coated with 100 µg/ml poly-L-lysine
and cultured in Neurobasal media (GIBCO, Carlsbad, CA,
USA) supplemented with 2% B27 supplement (GIBCO), 0.5
mM glutamine (GIBCO), 25 µM glutamate (Sigma-Aldrich),
penicillin/streptomycin (GIBCO, 20 unit/ml), 1 mM HEPES
(Sigma-Aldrich), and 1% heat inactivated donor horse serum
(GIBCO). The cultures were incubated in a tissue culture
incubator at 37◦C in 5% CO2. On days in vitro (DIV) 1, 4
and 7, half of the culture media was replaced with fresh media
without horse serum. OnDIV 4 and 7, 2µMcytosine arabinoside
(Sigma-Aldrich) was added to reduce the glial cell populations.
On DIV 9, the cells were treated with different concentrations
(0, 1, 10, 50, or 100 µM) of NaHS (Sigma-Aldrich) and 1 µM
oligomeric Aβ42 or vehicle at different time points, as shown
in the timeline (Figure 1A). Oligomeric Aβ42 was prepared
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FIGURE 1 | Schematic diagram of this study. (A) The experimental timeline for the in vitro experiment. Embryonic (E 16–18) hippocampi were isolated for primary
culture. At DIV 9, different doses of NaHS (1, 10, 50 or 100 µM) were applied to the hippocampal primary cultures 30 min before (pre-treatment), after
(post-treatment), or simultaneously with (co-treatment) the application of oligomeric Aβ42. Cells were harvested for IF staining with NeuN and MAP2 antibodies after
treatment with oligomeric Aβ42 for 1 h. (B) The experimental timeline for the in vivo treatments and assays. NaHS (arrows) was applied over the first 5 days and each
foot shock and SR (arrowheads) on days 8, 13, 20, 32. OF and EPM tests were conducted to measure anxiety levels. The MWM was conducted on days 24–31 to
assess the spatial learning and memory of the mice. After SR4, all mice were sacrificed for pathological analyses on day 33.
as previously described (Kayed et al., 2003), and vehicle was
prepared according to the same procedure but without Aβ42
powder.
Immunocytochemistry Analysis
Cells were harvested for immunofluorescence (IF) staining
after oligomeric Aβ42 administration for 1 h. The cells were
first fixed with ice-cold 4% paraformaldehyde (Sigma-Aldrich)
for 30 min and washed with phosphate-buffered saline with
Triton X-100 (PBST) three times for 10 min each. Non-specific
reactivity was blocked by incubation with 10% fetal bovine
serum (FBS) for 2 h. The cells were then incubated with
NeuN (1:1000; Millipore) andMAP2 (1:1000; Millipore) primary
antibodies for 16 h at 4◦C, followed by incubation with a
secondary antibody for 2 h at 37◦C. Finally, neuronal nuclei
were counterstained with 4′,6-diamino-2-phenylindole (DAPI;
Sigma-Aldrich) and immediately analyzed using a High Content
Micro-Imaging Acquisition and Screening System (Molecular
Devices, Sunnyvale, CA, USA). Both the percentage of neurons
and neurite length were analyzed by MetaXpress application
software (Molecular Devices).
Animal Experimental Timeline
The mice received a footshock and SRs as described in a previous
study (Huang et al., 2010). As depicted in Figure 1B, the 3 ×
Tg-AD mice (n = 60) were habituated to their home cages and
were handled once per day on days 1–5. After adaptation, the
mice were placed in the shock chamber (300 × 300 × 350
mm). In the footshock-stimulated group, an inescapable electric
footshock was delivered (0.8 mA, 10-s duration, 10-s interval)
to the mice after a 120-s acclimation period on days 6 and
7. The non-footshock group did not receive foot shocks. The
mice were re-exposed to the same chamber on days 8, 13, 20,
and 32, but did not receive foot shock (indicated as SRs 1,
2, 3, and 4). The dose and timing of the NaHS treatment in
mice were determined based on results in primary hippocampal
neuronal cultures and slightly modified according to a previous
study (Zhang et al., 2013). Thus, 2.5 mg/kg (45 µM) was
applied in vivo via intraperitoneal (ip) injection. To maintain
the corresponding concentrations, the treatment was conducted
twice a day. The mice received either saline or NaHS (2.5
mg/kg, twice a day) via intraperitoneal injection before footshock
and each SR on days 1–8, 13, 20, and 32. The male 3×Tg-
AD mice were randomly assigned to four groups (n = 15/
group): (i) non-footshock/saline; (ii) non-footshock/NaHS;
(iii) footshock/saline; and (iv) footshock/NaHS. To evaluate
anxiety-like or risk-assessment behaviors, the open-field (OF)
test and Elevated plus maze (EPM) were used on days 22–23.
On days 24–31, the Morris water maze (MWM) task was
conducted, and blood samples were collected to measure the
plasma concentration of H2S. On day 33, the mice were
sacrificed and subjected to pathological characterization using
enzyme-linked immunosorbent assay (ELISA),Western blot, and
immunohistochemistry analyses.
Open-Field (OF) Test
The OF test was modified as previously described (Shang et al.,
2015). In brief, the OF test was conducted in a white OF box
(30 cm × 30 cm × 30 cm) under diffuse lighting. Mice were
carefully placed in the center of the box and allowed to explore
freely for 5 min in the absence of an observer. After each
trial, the box was cleaned, and the animal was returned to the
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home cage. The arena was partitioned to create a ‘‘center’’ zone
(15 cm× 15 cm) and a ‘‘corner’’ zone consisting of the remaining
area. A camera mounted on the ceiling above the chamber and
connected to an automated video tracking system (EthoVision,
Nodulus, Wageningen, Netherlands) was used to capture and
quantify images.
Elevated Plus Maze (EPM)
The EPM consisted of four arms (30 × 5 cm) that were elevated
50 cm above floor level. Two of the arms contained 15-cm-high
walls (enclosed arms), while the other two arms remained open
(open arms). Each mouse was placed in the middle section facing
an open arm and was allowed to explore the maze for a single
5-min session during which the experimenter was out of view.
After each trial, the floor was sequentially cleaned with 70% and
30% ethanol. The number of entries, duration spent, and total
distances traveled were measured for both types of arms using a
video camera and were analyzed with the video tracking system
(Nodulus).
Morris Water Maze (MWM)
The MWM task was conducted as previously described (Huang
et al., 2014). Briefly, the system consisted of a circular pool
(height 47 cm, diameter 100 cm) filled with opaque water (24
± 1◦C) to a depth of 40 cm. A hidden square platform (10
cm2) was submerged 1 cm below the surface of the water in the
center of the northeast quadrant as the target quadrant. A video
camera was attached to the ceiling to record the behavior of the
mice in the pool and was interfaced with EthoVision software
(Nodulus).
The experimental procedures included pretraining, training,
testing, and probing. During pretraining, the mice were adapted
to the pool, and their swimming ability was assessed by allowing
them to swim for 60 swithout the platform during each of three
60 s pretraining trials. After each of the three acclimatization
trials, the mouse was placed on the hidden platform and allowed
to remain on the platform for 20 s. After pretraining, each mouse
received training that consisted of 16 trials (four trials per day,
lasting a maximum of 60 s each, with an intertrial interval of
20–30 min). The mouse was released into the water from a
starting point that randomly varied between trials. When the
mouse reached the platform, it was allowed to remain there for
20 s. If themouse did not find the platform before the 60 s cut-off,
it was placed on the platform and allowed to stay there for 20 s.
The latency to escape from the water maze (finding the hidden
platform) was calculated for each trial. Twenty-four hours after
the final training trial, the mice underwent three testing trials
to determine the time required to find the hidden platform as a
measure of spatial learning acquisition. In the probe trials, which
occurred 2 and 48 h after the end of the testing trials, short-
and long-term spatial memory were evaluated in the maze with
no platform. The probe test was conducted by allowing each
mouse to swim freely for 60 s. The time the mice spent in the
target quadrant was measured to represent the degree of memory
consolidation after learning.
Immunohistochemistry
The immunohistochemical procedures were performed as
previously described (Huang et al., 2012). Briefly, after the
behavioral test, the mice (n = 3–5 per group) were deeply
anesthetized with avertin (0.4 g/kg body weight) and then
perfused with 4% paraformaldehyde in 0.1 M PBS. The mouse
brains were removed and post-fixed in the same solution
at 4◦C for 24 h. Then, the brains were dehydrated in
a graded series of sucrose solutions until fully permeated.
Coronal sections were cut on a cryostat microtome (CMS3050S,
Leica Microsystems, Nussloch, Germany) at a thickness of
30 µm. Free-floating sections were incubated with primary
antibodies (Table 1) overnight at room temperature, followed
by incubation with the appropriate biotinylated secondary
antibodies (1:200 dilution, Vector Laboratories, CA, USA) and
avidin-biotin-peroxidase complex (Vectastain Elite ABC kit;
Vector Laboratories, CA, USA) for 1 h at room temperature.
Immunoreactivity was visualized with a diaminobenzidine
(DAB) kit (Vector Laboratories, CA, USA). All sections from
each group of three to five mice were observed using a
light microscope (Leica, Wetzlar, Germany), and images were
obtained using the Image-Pro Plus 5.1 image-analysis system
(Image Pro Plus Media Cybernetics, Washington, MD, USA).
The positive immunohistochemical signal within a specific field
was first indicated as the standard signal, and the number of
immunopositive cells was then counted using the image-analysis
system.
Western Blot Analysis
Isolated hippocampal tissues were homogenized, and the
concentration of the isolated proteins was then determined
using a bicinchoninic acid (BCA) protein assay kit (Thermo,
Rockford, IL, USA) (n = 3–5 per group). The homogenates
TABLE 1 | List of primary antibodies.
Antibody Species Supplier WB dilution IHC dilution
APP Rabbit Sigma-Aldrich 1:1000 –
BACE1 Rabbit Cell Signaling 1:1000 –
5-HT Rat Millipore – 1:200
ChAT Rabbit Millipore – 1:1000
TH Rabbit Millipore – 1:1000
iNOS Rabbit Millipore 1:1000 –
MnSOD Rabbit Millipore 1:1000 –
GFAP Mouse Millipore – 1:1000
Iba-1 Rabbit Wako – 1:1000
CDK5 Mouse Millipore 1:1000 –
p38 Rabbit Cell Signaling 1:1000 –
pp38 Rabbit Cell Signaling 1:1000 –
pS202Tau Rabbit AnaSpec 1:1000 –
pS262Tau Rabbit Millipore 1:1000 –
pS396Tau Rabbit Invitrogen 1:1000 –
pT231Tau Rabbit Invitrogen 1:1000 –
GSK3β Rabbit Epitomics 1:1000 –
pGSK3β Rabbit Epitomics 1:1000 –
CRF Goat Santa Cruz 1:1000 –
β-actin Mouse Millipore 1:2000 –
WB, Western blot; IHC, immunohistochemistry.
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(25 µg of protein) were subsequently separated by SDS-PAGE
and transferred to PVDF membranes. The membranes were
then blocked in 5% (w/v) skim milk to reduce nonspecific
binding and probed with various primary antibodies, as listed in
Table 1. The secondary antibodies corresponded to the type of
primary antibody and included horseradish peroxidase (HRP)-
conjugated anti-mouse or anti-rabbit IgG (1:10,000, Amersham
Pharmacia Biotech, Piscataway, NJ, USA). Protein bands were
visualized using an enhanced chemiluminescence detection
system (Amersham). Protein bands were quantified using an
LAS-4000 chemiluminescence detection system (Fujifilm, Tokyo,
Japan). The target protein density was normalized to β-actin
levels, and protein level changes in the brain tissues of mice
treated with footshock are presented relative to the control group.
The changes in protein levels refer to control levels to compare
experimental conditions.
Enzyme-Linked Immunosorbent Assay Analysis
Blood was harvested from a facial vein by lancet after the SRs.
The blood was mixed with heparin (20 units/ml) and centrifuged
at 2000× g for 20 min at 4◦C. The supernatant was collected as a
plasma sample to detect the levels of GSH and IL-6 in accordance
with the instructions of the glutathione assay kit (Cayman
Chemical, Ann Arbor, MI, USA) and IL-6 ELISA kit (R&D
Systems, Minneapolis, MN, USA). Mouse Aβ40 (KMB3481) and
Aβ42 (KMB3441) immunoassay kits (Biosource International,
Camarillo, CA, USA) were used to determine Aβ40 and Aβ42
levels in the brain tissues of the mice. ELISAs were performed
according to the manufacturer’s protocol as previously described
(Huang et al., 2011).
Measurement of H2S Concentration in Plasma
After the MWM, mouse blood was collected, and plasma H2S
levels were analyzed as described previously (Zhuo et al., 2009).
Plasma (75 µl) was mixed with 250 µl of 1% zinc acetate (Sigma;
St. Louis, MO, USA) and 425 µl of water and incubated for 10
min at room temperature. Trichloroacetic acid (250µl 10% TCA;
J.T. Baker, Center Valley, PA, USA) was added to the mixture,
which was then centrifuged for 15 min at 14,000× g. The clear
supernatant was collected and mixed with equal volumes of 20
mM N-dimethyl-p-phenylenediamine sulfate (Acros Organics,
Fair Lawn, NJ, USA) in 7.2 M HCl (Sigma) and 30 mM FeCl3
(Sigma) in 1.2 M HCl. After 20 min, the absorbance of the
mixture at 670 nm was measured using a microplate reader
(Multiskan GO, Thermo). The H2S concentration was calculated
as previously described (He et al., 2014).
Data Analysis
In vitro data, data for the OF and MWM tests, and plasma H2S
levels were compared via two-way analysis of variance (ANOVA)
followed by LSD post hoc tests for multiple comparisons. The
nonparametric EPM data were evaluated using the Kruskal
Wallis test. To analyze the pathology measures, ANOVA was
performed to compare the parametric data between the three
groups, followed by LSD tests for post hocmultiple comparisons.
SPSS 16.0 software was used to analyze the data. The results
are expressed as the mean ± SEM. Differences were considered
statistically significant at p< 0.05.
RESULTS
NaHS Attenuates Oligomeric Aβ42-Induced
Neurotoxicity in mouse Hippocampal
Primary Neuronal Cultures
To evaluate the effect of NaHS on oligomeric Aβ42 treated-
hippocampal primary neuronal cultures, we applied different
doses of NaHS at different times (pre-treatment, post-treatment
or co-treatment) relative to the application of oligomeric Aβ42.
Compared with vehicle treatment, treatment with oligomeric
Aβ42 significantly decreased the percentage of mature neurons
(identified by NeuN staining) when applied pre- (F(1,57) =
33.94, p < 0.0001; Figures 2A,B), co- (F(1,59) = 47.77, p <
0.0001; Figures 2A,C), or post- (F(1,57) = 5.80, p < 0.05;
Figures 2A,D) NaHS treatment. Compared with the vehicle
treatment, the application of oligomeric Aβ42 also significantly
decreased neurite length (based onMAP2 staining) when applied
pre- (F(1,57) = 18.01, p < 0.001; Figures 2A,E), co- (F(1,59) =
15.18, p < 0.001; Figures 2A,F), or post- (F(1,57) = 11.98, p <
0.01; Figures 2A,G) NaHS treatment. However, pre-, co-, and
post-treatment with different doses of NaHS did not affect the
percentage of mature neurons compared to saline treatment
(p > 0.05; Figures 2A–D). In addition, pre-treatment (F(4,57)
= 19.42, p < 0.001; Figures 2A,E) and co-treatment (F(4,59) =
4.10, p < 0.01; Figures 2A,F) with NaHS significantly increased
neurite length compared with saline treatment. There was no
significant interaction effect between the oligomeric Aβ42 and
NaHS treatments on the percentage of mature neurons or neurite
length (p > 0.05). Post hoc multiple comparisons revealed that
post-treatment with 10 µM NaHS significantly increased the
percentage of mature neurons compared to oligomeric Aβ42
treatment (p < 0.05; Figure 2D). Neurite length was also
significantly increased by 50 µM pre- (p < 0.01) and co- (p <
0.05) NaHS treatment comparedwith oligomeric Aβ42 treatment.
Notably, pre- (p< 0.05) and post- (p< 0.01) treatment with a low
dose (1 or 10 µM) of NaHS significantly increased neurite length
compared to saline treatment. However, pre-treatment with a
high dose (100 µM) of NaHS significantly decreased neurite
length compared to treatment with oligomeric Aβ42 (p < 0.001).
These results suggest that oligomeric Aβ42 induces neurotoxicity,
whereas NaHS treatment ameliorates oligomeric Aβ42-induced
neuronal damage.
NaHS Increases Plasma H2S and
Ameliorates Anxiety-Like behaviors in
Footshock-Stimulated 3×Tg-AD Mice
To exacerbate the 3×Tg-AD phenotype, inescapable footshock
with SRs was conducted on the mice. Based on the optimal
dose (50 µM) identified in the experiments with primary
hippocampal neuronal cultures and a previous study (Zhang
et al., 2013), we administered 45 µM NaHS (2.5 mg/kg; twice
per day) via intraperitoneal injection on days 1–8, 13, 20, and
32. Plasma H2S levels were measured after the MWM, and the
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FIGURE 2 | Timing and doses of the NaHS treatments in mouse hippocampal primary neuronal cultures incubated with oligomeric Aβ42.
(A) Representative immunofluorescence images of primary cultures stained for NeuN (red), MAP2 (green) and DAPI (blue). Scale bar: 100 µM. (B–D) Quantification
of the percentage of mature neurons relative to all cells in oligomeric Aβ42-treated primary cultures that also received pre-, co-, and post-treatment with NaHS.
(E–G) Quantification of neurite length in oligomeric Aβ42-treated primary cultures that also received pre-, co-, and post-treatment with NaHS. The arrowheads
indicate positive staining (n = 3 per group). Data are expressed as the mean ± SEM. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
results demonstrated that footshock significantly reduced plasma
H2S concentrations (F(1,24) = 25.72, p < 0.001; Figure 3A).
NaHS administration significantly increased plasma H2S levels
(F(1,24) = 77.38, p < 0.001; Figure 3A). There was significant
interaction between footshock and NaHS (F(1,24) = 6.91, p <
0.05; Figure 3A). To evaluate the anxiolytic effect of NaHS on
the mice, both the OF and EPM tests were conducted. Footshock
mice spent significantly less time in the central zone of the OF
arena (F(1,19) = 15.75, p< 0.01; Figure 3B), and NaHS treatment
significantly increased the duration spent in the central zone
(F(1,19) = 5.41, p < 0.05; Figure 3B). There was also significant
interaction between footshock andNaHS (F(1,19) = 6.85, p< 0.05;
Figure 3B). In the EPM, the frequency with which the footshock-
stimulated mice visited the open arms was significantly reduced
(p < 0.05; Figures 3C,D), and NaHS treatment ameliorated
the effect of anxiety, as indicated by the increased amount
of time the NaHS-treated mice spent in the open arm (p
< 0.05; Figure 3C; p < 0.001; Figure 3D). There were no
significant differences in the total distance traveled between
the four groups (p > 0.05; Figure 3E). Therefore, footshock
with SRs induced anxiety-like behaviors and was associated
with reduced plasma H2S levels in the 3×Tg-AD mice. The
semi-acute administration of NaHS increased plasma H2S levels
and had an anti-anxiety effect in the footshock-stimulated 3×
Tg-AD mice.
NaHS Reduces Amyloid Deposition
and Tau Protein Phosphorylation
in the Amygdala in 3×Tg-AD Mice
Under Footshock Stimuli
The amygdala mediates anxiety and goal-directed responses
(Coutureau et al., 2009; Hubert and Muly, 2014).
Immunohistochemical staining revealed that the levels of Aβ40
(F(2,15) = 16.18, p < 0.001; Figure 4 and Table 2), Aβ42 (F(2,20) =
18.78, p < 0.001; Figure 4 and Table 2) and phosphorylated tau
protein S202 (pS202 Tau) (F(2,23) = 19.45, p< 0.001; Figure 4 and
Table 2) in the basolateral nucleus of amygdala (BLA) differed
significantly between the non-footshock/saline, footshock/saline,
and footshock/NaHS groups. In the footshock/saline group, the
levels of Aβ40 (p < 0.001; Figure 4 and Table 2), Aβ42 (p <
0.001; Figure 4 and Table 2), and pS202 Tau (p< 0.001; Figure 4
and Table 2) in the BLA were significantly greater than in the
non-footshock/saline (control) group. However, the levels of
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FIGURE 3 | The effects of NaHS treatment on plasma H2S levels and anxiety. (A) H2S concentrations were measured in mouse plasma collected after the
MWM. H2S levels were reduced in the footshock-stimulated animals, and NaHS treatment recovered the H2S levels. (B) Time spent in the central zone during the OF
test. The animals in the footshock/NaHS group spent more time in the central zone than those in the footshock/saline group. The data are the mean ± SEM of each
group (n = 15 per group). ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. (C,D) Duration in the open arms and the open/enclosed arm ratio for the four groups. The duration in
the open arm and the open/enclosed arm ratio were greater in the footshock/NaHS group than in the footshock/saline group. (E) Total distance traveled in the EPM.
During the period of the EPM task, the total moved traveled did not differ between any of the groups of mice. Data are mean ± SEM of each group (n = 15 per
group). #p < 0.05, compared to the non-footshock/saline group. ∗p < 0.05 and ∗∗∗p < 0.001, compared to the footshock/saline group.
Aβ40 (p< 0.001; Figure 4 and Table 2), Aβ42 (p< 0.001; Figure 2
and Table 2), and pS202 Tau (p < 0.001; Figure 4 and Table 2)
were significantly lower in the BLA in the footshock/NaHS
group than in the footshock/saline group. These results indicate
that amyloid deposition and phosphorylated tau protein levels
were increased in the footshock-treated mice, whereas semi-
acute treatment with NaHS attenuated the footshock-induced
pathological changes in the BLA in 3×Tg-AD mice.
NaHS Attenuates the Impairment of Spatial
Learning and Memory in 3×Tg-AD Mice
under Footshock Stimuli
Of the regions in the brain, the hippocampus is the most
vulnerable to stressful conditions (Semmler et al., 2005).To
investigate the effects of footshock and/or NaHS treatment on
spatial cognition, we employed the MWM task to examine
hippocampus-dependent learning and memory. All animals
swam normally during the pretraining trials (p > 0.05;
Figure 5A). During the training phase of the MWM, the
footshock/saline group did not exhibit a significant decrease
in escape latency onto the platform following training days
1–4 (p = 0.07; Figure 5B); however, the escape latency of
the footshock/NaHS group was significantly decreased (F(3,39)
= 11.36, p < 0.001; Figure 5B). By contrast, the escape
latency onto the platform of the non-footshock group was also
significantly decreased with saline (F(3,27) = 14.47, p < 0.001;
Figure 5B) and NaHS (F(3,15) = 16.185, p < 0.001; Figure 5B)
treatment. The escape latency of the footshock/saline group on
training day 4 was significantly greater than that of the non-
footshock/saline group (p < 0.01; Figure 5B). However, the
escape latency of the footshock/NaHS group on training days
3 (p < 0.01; Figure 3B) and 4 (p < 0.001; Figure 5B) was
significantly decreased compared to that of the footshock/saline
group.
During the test period, the time spent searching for the
platform was assessed as an indicator of the acquisition of spatial
learning. The spatial learning acquisition was significantly lower
in the footshock group than in the non-footshock group (F(1,33)
= 2.79, p < 0.01; Figure 5C). However, compared with saline
treatment, NaHS treatment significantly attenuated the deficit in
spatial learning acquisition (F(1,33) = 3.54, p< 0.001; Figure 5C).
There was also a significant interaction between footshock and
NaHS in spatial learning acquisition (F(1,33) = 4.5, p < 0.001;
Figure 5C). Post hoc multiple comparisons revealed that the
deficit in spatial learning acquisition was significantly lower in
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FIGURE 4 | The effect of NaHS on the level of amyloid deposition and pS202 Tau in footshock-stimulated 3×Tg-AD mice. Representative immunostaining
for Aβ40 (A–C). Aβ42 (D–F) and pS202 Tau (G–I) in the BLA. Scale bar = 100 µm. The arrowheads indicate positive staining for Aβ40, Aβ42, and pS202 Tau (n = 3–5
per group).
TABLE 2 | Immunohistochemistry results for mice receiving different treatments.
Control Footshock/Saline Footshock/NaHS
Aβ40 in CA1 71.86 ± 1.14 118.25 ± 1.12a∗∗∗ 72.63 ± 1.75b∗∗∗
Aβ40 in BLA 114.00 ± 7.00 161.25 ± 14.28a∗∗∗ 103.14 ± 15.38b∗∗∗
Aβ42 in CA1 41.71 ± 1.78 82.40 ± 0.94a∗∗∗ 47.89 ± 1.26b∗∗∗
Aβ42 in BLA 61.71 ± 2.22 163.00 ± 4.15a∗∗∗ 82.22 ± 2.66b∗∗∗
PS202 Tau in CA1 14.00 ± 0.70 26.50 ± 0.35a∗ 6.25 ± 0.35a∗,b∗∗∗
PS202 Tau in BLA 26.27 ± 0.88 59.20 ± 0.12a∗∗∗ 27.88 ± 0.11b∗∗∗
Iba1 in hippocampus 41.75 ± 0.88 58.67 ± 0.98a∗∗ 29.42 ± 0.88a∗∗,b∗∗∗
Iba1 in amygdala 32.55 ± 0.53 67.67 ± 0.68a∗∗∗ 39.17 ± 0.63b∗∗∗
GFAP in hippocampus 16.83 ± 0.48 43.20 ± 1.02a∗∗∗ 19.20 ± 0.83b∗∗∗
ChAT in MS/DB 191.38 ± 4.44 122.75 ± 1.87a∗∗ 222.00 ± 1.89b∗∗∗
TH in LC 63.80 ± 1.13 49.40 ± 0.64a∗ 70.75 ± 0.86b∗∗
Each value represents the mean ± SEM (n = 3–5 per group).acompared to the control group.bcompared to the footshock/saline group. CA1, CA1 subregion of the
hippocampus; BLA, basolateral nucleus of the amygdala; ChAT, Cholinergic-reactive neurons; MS/DB, medial septum/diagonal band of Broca; TH, noradrenergic-reactive
neurons; LC, locus coeruleus. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
the footshock/NaHS group than in the footshock/saline group
(p< 0.001; Figure 5C).
Two hours after the end of the testing trials, retrieval of
short-term memory was significantly impaired in the footshock
group compared to the non-footshock group (F(1,20) = 7.43,
p < 0.05; Figure 5D). The administration of NaHS significantly
reduced the deficit in short-term memory retrieval compared
with saline treatment (F(1,20) = 31.62, p < 0.001; Figure 5D).
There was also a significant interaction between footshock and
NaHS (F(1,20) = 8.68, p < 0.01; Figure 5D). Forty-eight hours
after the end of the testing trials, the retrieval of long-term
memory was further assessed. An impairment of long-term
memory retrieval was not observed in the footshock group
compared to the non-footshock group (p = 0.85; Figure 5D).
However, NaHS treatment significantly prevented the deficit
in long-term memory retrieval compared to saline treatment
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FIGURE 5 | NaHS treatment attenuated the impairment of cognition in footshock-stimulated 3×Tg-AD mice. (A) Swimming velocity of the mice in the
MWM. The mice in all groups had the same swimming ability. (B) Learning trends of the mice over the 4 training days of the MWM. Footshock accelerated the
impairment of spatial learning ability and acquisition, and NaHS reduced the impairment in the footshock group. (C) The latency of mice to find the platform in the
testing trials. The mice under footshock took longer to climb onto the platform than the control mice, and NaHS treatment ameliorated the impairment in the
footshock group. (D) The results of short- and long-term memory retrieval. A probe trial was conducted 2 and 48 h after the last testing trial to evaluate short- and
long-term memory retrieval. Footshock enhanced the impairment of short- and long-term memory retrieval, and NaHS attenuated the deficit. The data are the mean
± SEM of each group (n = 15 per group). ∗∗p < 0.01; ∗∗∗p < 0.001. ##p < 0.01 for comparisons with the non-footshock/saline group.
(F(1,20) = 28.66, p < 0.001; Figure 5D). In addition, there
was a significant interaction between footshock and NaHS
(F(1,20) = 25.67, p < 0.001; Figure 5D). Post hoc multiple
comparisons revealed that the footshock/saline group exhibited
significant impairment of long-termmemory retrieval compared
with the non-footshock/saline group (p < 0.001; Figure 5D).
These results indicate that footshock with SRs exacerbated the
impairment of spatial learning and memory and that semi-
acute treatment with NaHS ameliorated these impairments in the
footshock-stimulated 3×Tg-AD mice. However, the semi-acute
administration of NaHS had no effect on cognition or emotion in
the 3×Tg-AD mice without footshock. Therefore, three groups
of mice, non-footshock/saline (control), footshock/saline, and
footshock/NaHS, were subjected to further pathological analyses.
NaHS Strongly Attenuates
Amyloidogenesis in the Hippocampus
in 3×Tg-AD Mice under Footshock
Stimulus
The level of Aβ deposition in the hippocampus plays an
important role in the loss of cognitive function in AD. Therefore,
we examined BACE1 and Aβ levels in the hippocampus
in 3×Tg-AD mice. BACE1 expression differed significantly
between the three groups (F(2,8) = 8.97, p < 0.05; Figure 6A).
A significantly higher level of BACE1 was observed in the
footshock/saline group compared to the control group (p <
0.01; Figure 6A). However, the level of BACE1 was significantly
decreased in the footshock/NaHS group compared to the
footshock/saline group (p< 0.05; Figure 6A). Guanidine-soluble
Aβ40 and Aβ42 levels in the hippocampus were measured using a
sensitive sandwich ELISA, which revealed significant differences
in Aβ40 (F(2,8) = 44.03, p < 0.001; Figure 6B) and Aβ42 (F(2,8) =
13.72, p < 0.01; Figure 6C) levels between the three groups. In
addition, the levels of Aβ40 and Aβ42 were significantly greater
in the footshock/saline group than in the control group (p <
0.01; Figures 6B,C), and NaHS treatment reduced the levels of
Aβ40 (p < 0.01; Figure 6B) and Aβ42 (p < 0.001; Figure 6C)
compared to the footshock/saline group. The levels of Aβ40
(F(2,18) = 16.18, p < 0.001; Figure 7 and Table 2) and Aβ42
(F(2,20) = 13.87, p < 0.001; Figure 7 and Table 2) in the CA1
subregion of the hippocampus differed significantly between the
three groups. Post hoc LSD multiple comparisons indicated that
footshock significantly increased the level of Aβ in area CA1
of the hippocampus compared with the Aβ level in the control
group (p < 0.001; Figure 7 and Table 2), and the level of
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FIGURE 6 | NaHS treatment decreased the levels of Aβ and BACE1 in the hippocampi of mice under footshock stimulus. (A) Representative Western blot
and densitometry for BACE1 in the mouse hippocampus. β-Actin was used as the internal control. (B) Aβ40 levels in the mouse hippocampus analyzed by ELISA.
(C) Aβ42 levels in the mouse hippocampus measured by ELISA. The data are the mean ± SEM of each group (n = 3–5 per group). ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p <
0.001. a, compared to the control group. b, compared to the footshock/saline group.
Aβ in area CA1 of the hippocampus was significantly lower in
the footshock/NaHS group than in the footshock/saline group
(p < 0.001; Figure 7 and Table 2). These results suggest that
semi-acute treatment with NaHS attenuated amyloidogenesis
in the hippocampus in association with a reduced level of
hippocampal BACE1 in the 3×Tg-AD mice under footshock
stimulus.
NaHS Reduces Tau Protein
Hyperphosphorylation Associated with
Increased pS9-GSK3β in 3×Tg-AD Mice
under Footshock Stimulus
Immunohistochemical staining demonstrated that, in addition to
Aβ levels, the levels of pS202 Tau in area CA1 of the hippocampus
differed significantly between the three groups (F(2,14) = 14.42,
p < 0.001; Figure 7 and Table 2). Furthermore, footshock
significantly increased the level of pS202 Tau in area CA1 of the
hippocampus (p < 0.05; Figure 7 and Table 2), whereas NaHS
treatment in footshock-stimulated mice significantly reduced
pS202 Tau levels (p< 0.001; Figure 7 and Table 2). Hippocampal
levels of various forms of phosphorylated tau protein were
further characterized by Western blot. We observed significant
differences between the three groups in the levels of tau protein
phosphorylated at S396 (F(2,8) = 6.94, p < 0.05; Figures 8A,B),
S202 (F(2,8) = 5.70, p < 0.05; Figures 8A,C), and T231 (F(2,8)
= 9.55, p < 0.05; Figures 8A,D). The levels of tau protein
phosphorylated at S396 (p < 0.05; Figures 8A,B), S202 (p <
0.05; Figures 8A,C) and T231 (p < 0.01; Figures 8A,D) were
significantly increased in the footshock/saline group compared
to the control group. However, the levels of tau protein
phosphorylated at S396 (p < 0.05; Figures 8A,B), S202 (p <
0.05; Figures 8A,C), and T231 (p < 0.05; Figures 8A,D) were
significantly reduced in the footshock/NaHS group compared
to the footshock/saline group. Regarding the kinases that
phosphorylate tau protein, we observed significant differences
between the three groups in the inactive form of GSK3β (pS9-
GSK3β) (F(2,8) = 18.47, p < 0.01; Figures 8A,E) but not CDK5
(data not shown). The pS9-GSK3β/GSK3β ratio was significantly
lower in the footshock/saline group compared to the control
group (p < 0.05; Figures 8A,E) but significantly higher in
the footshock/NaHS group compared to the footshock/saline (p
< 0.01; Figures 8A,E) and control (p < 0.05; Figures 8A,E)
groups. Therefore, footshock with SRs increased the levels of
phosphorylated tau proteins in the hippocampus, but the semi-
acute administration of NaHS considerably reduced the tau
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FIGURE 7 | NaHS decreased the levels of Aβ and phosphorylated tau protein in the hippocampal CA1 subregion of the footshock-stimulated mice.
(A–F) Representative immunostaining for Aβ40 and Aβ42 in area CA1 of the mouse hippocampus. Scale bar = 50 µm. (G–I) Representative immunostaining for tau
protein phosphorylated at S202 (pS202 Tau) in area CA1 of the hippocampus. Scale bar = 100 µm. The arrowheads indicated positive staining for Aβ40, Aβ42, and
pS202 Tau (n = 3–5 per group).
FIGURE 8 | NaHS decreased the levels of various forms of phosphorylated tau protein and increased the level of pS9GSK3β in the hippocampus of
mice under footshock. Representative Western blots (A) and densitometry for phosphorylated tau (Ser396; B), (Ser202; C), and (Thr231; D) as well as the
pS9GSK3β/GSK3β ratio (E). Tau 5 was used for total tau, with β-actin as the internal control. The quantitative data are the mean ± SEM of each group (n = 3–5 per
group). ∗p < 0.05; ∗∗p < 0.01. a, compared to the control group. b, compared to the footshock/saline group.
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hyperphosphorylation associated with increasing hippocampal
pS9-GSK3β levels in the footshock-stimulated 3×Tg-AD mice.
NaHS Decreases Inflammatory Responses,
Oxidative Stress, and Gliosis in 3×Tg-AD
Mice under Footshock Stimulus
Oxidative stress and inflammation in both the hippocampus
and plasma were also evaluated. In the three groups, there were
significant differences in the levels of IL-6 in plasma (F(2,10)
= 22.14, p < 0.001; Figure 9A), iNOS in the hippocampus
(F(2,8) = 56.15, p < 0.001; Figure 9B), GSH in plasma (F(2,17)
= 9.55, p < 0.05; Figure 9C), and MnSOD in the hippocampus
(F(2,8) = 37.31, p < 0.001; Figure 9D). Compared with the
control group, the footshock/saline group exhibited significant
increases in IL-6 in plasma (p < 0.01; Figure 9A) and in iNOS
in the hippocampus (p < 0.001; Figure 9B) and significant
decreases in plasma GSH (p< 0.05; Figure 9C) and hippocampal
MnSOD (p < 0.001; Figure 9D). We also detected lower levels
of plasma IL-6 (p < 0.001; Figure 9A) and hippocampal iNOS
(p < 0.001; Figure 9B) and higher levels of plasma GSH (p
< 0.001; Figure 9C) and hippocampal MnSOD (p < 0.001;
Figure 9D) in the footshock/NaHS group compared to the
footshock/saline group. The level of hippocampal iNOS was
lower in the footshock/NaHS group than the control group (p <
0.01; Figure 9B). In addition, our results demonstrated that
footshock with SRs did not alter inflammatory-related pathways,
including COX2, NF-κB, and MAPK, in the hippocampi of
3×Tg-AD mice (data not shown).
We further investigated whether neuroinflammation in the
hippocampus and amygdala was affected. The number of reactive
astrocytes in the hippocampus differed significantly between the
three groups of mice (F(2,15) = 18.23, p < 0.001; Figure 10 and
Table 2). The numbers of reactive microglia in the hippocampus
(F(2,25) = 21.19, p < 0.001; Figure 10 and Table 2) as well as
in the BLA (F(2,22) = 69.25, p < 0.001; Figure 10 and Table 2)
also differed significantly between the three groups of mice.
The number of reactive astrocytes in the hippocampus of the
footshock/saline group was increased compared to the control
group (p < 0.001; Figure 10 and Table 2). The numbers of
reactive microglia in the hippocampus (p < 0.01; Figure 10 and
Table 2) and BLA (p < 0.001; Figure 10 and Table 2) were
also increased in the footshock/saline group compared with the
control group. However, compared with the numbers in the
FIGURE 9 | Antioxidative and anti-inflammatory activity of NaHS in mice under footshock. (A) Levels of the inflammatory cytokine IL-6 in mouse plasma
analyzed by ELISA. (B) Representative Western blot and densitometry for iNOS in the mouse hippocampus. Footshock strongly induced IL-6 and iNOS, and NaHS
ameliorated the inflammation. (C) Concentrations of GSH in mouse plasma measured by ELISA. (D) Representative Western blot and densitometry for MnSOD in the
hippocampus. Footshock reduced the levels of GSH and MnSOD, and NaHS improved the antioxidant capacity of the mice under footshock. β-Actin was used as
an internal control. The data are the mean ± SEM of each group (n = 3–5 per group). ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. a, compared to the control group.
b, compared to the footshock/saline group.
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FIGURE 10 | NaHS reduced neuroinflammation in mice with footshock. (A–C) Representative immunostaining of activated astrocytes (GFAP) in the CA1
subregion of the mouse hippocampus. (D–F) Representative immunostaining of activated microglia (Iba1) in the CA1 subregion of the mouse hippocampus.
(G-I) Representative immunostaining of activated microglia (Iba1) in the basolateral nucleus of the mouse amygdala (BLA). Scale bar = 100 µm. Arrowheads
indicated positive staining for GFAP and Iba1 (n = 3–5 per group).
footshock/saline group, significantly fewer activated astrocytes
(p< 0.001; Figure 10 andTable 2), microglia in the hippocampus
(p < 0.001; Figure 10 and Table 2), and microglia in the
BLA (p < 0.001; Figure 10 and Table 2) were observed in the
footshock/NaHS group. We also observed a decreased number
of reactive microglia in the hippocampus in the footshock/NaHS
group compared to the control group (p < 0.01; Figure 10
and Table 2). Therefore, the semi-acute administration of NaHS
decreased gliosis in the hippocampus and amygdala and reduced
inflammation and oxidative stress in the footshock-stimulated
3×Tg-AD mice.
NaHS Prevents Cholinergic and
Noradrenergic Neuronal Loss in 3×Tg-AD
Mice under Footshock Stimulus
In the three groups, we observed significant differences in the
number of cholinergic neurons in the MS/DB (F(2,15) = 8.97,
p < 0.01; Figure 11 and Table 2) and of noradrenergic neurons
in the LC (F(2,13) = 6.67, p< 0.05; Figure 11 and Table 2). Fewer
cholinergic (p < 0.01; Figure 11 and Table 2) and noradrenergic
(p < 0.05; Figure 11 and Table 2) neurons were observed in
the footshock/saline group compared with the control group.
However, compared with the footshock/saline group, cholinergic
(p < 0.001; Figure 11 and Table 2) and noradrenergic neuronal
loss (p < 0.01; Figure 11 and Table 2) did not occur in
the footshock/NaHS group. However, serotonergic neurons in
the raphe nucleus and pyramidal neurons in the hippocampus
were not altered in the mice that received footshock or NaHS
treatment (data not shown). These results suggest that the
semi-acute administration of NaHS prevented cholinergic and
noradrenergic neuronal loss in the footshock-stimulated 3×Tg-
AD mice.
DISCUSSION
In this study, we demonstrated that treatment with NaHS
attenuated oligomeric Aβ42-induced neurotoxicity in
hippocampal primary neuronal cultures. In vivo studies
indicated that footshock with SRs induced the impairment of
spatial cognition and emotion, which are involved in peripheral
and central systemic deficits including the hippocampus,
MS/DB, LC, and amygdala regions, whereas emotional and
cognitive dysfunction were attenuated by semi-acute treatment
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FIGURE 11 | NaHS prevented cholinergic and noradrenergic neuronal loss in mice under footshock. (A-C) Representative photomicrographs of cholinergic
neurons (ChAT staining) in the medial septum/diagonal band of Broca (MS/DB). Scale bar: 500 µM. (D-F) Representative photomicrographs of noradrenergic
neurons (TH staining) in the locus coeruleus (LC). Scale bar = 100 µm. Positive staining is indicated by arrows. n = 3–5 per group.
with NaHS through targeting multiple pathogenic cascade in the
3×Tg-AD mice.
First, we observed that pre- and co-treatment with 50 µM
of NaHS counteracted the decrease in neurite length caused
by oligomeric Aβ42-induced neurotoxicity. Pretreatment with a
2.5 mg/kg dose of NaHS can effectively reduce lesion volume
induced by traumatic brain injury (Zhang et al., 2013). In
addition, increasing the concentration of NaHS did not increase
the effect on neurite length. The administration of high doses
of NaHS of 10 mg/kg induces systemic inflammation in mice
(Bhatia et al., 2006; Zhang et al., 2007). Therefore, 2.5 mg/kg
NaHS was used in subsequent animal experiments.
Environmental risk factors due to inescapable footshock
with SRs increased anxiety-like behaviors as well as AD
pathology such as gliosis, amyloid deposition, and tau
hyperphosphorylation in the hippocampus and amygdala
of 3×Tg-AD mice. The hippocampus, amygdala, and prefrontal
cortex undergo stress-induced structural remodeling, which
alters behavioral and physiological responses (McEwen, 2013).
In addition, the hippocampus is the most vulnerable region of
the brain during stressful conditions (Semmler et al., 2005), and
a role for the amygdala in the onset of anxiety behaviors has been
demonstrated (Poulos et al., 2009) The amygdala is a component
of the limbic system and is involved in emotion and a variety
of cognitive functions due to its extensive connections with
many brain areas, such as the hippocampus (Yao et al., 2013).
Tauopathy begins in the CA1 subregion of hippocampus in
3×Tg-AD mice (Oddo et al., 2003), followed by the progression
of tauopathy to other areas such as the amygdala (Yamin, 2009).
Therefore, we evaluated the performance of these mice on the OF
and EPM as well as biochemical alterations in the hippocampus
and amygdala. Footshock-stimulated mice exhibited increased
anxiety or a ‘‘risk assessment’’ behaviors, as evidenced by reduced
visits to the open arms of the maze or increased duration in
the central zone (Walf and Frye, 2007; Szakács et al., 2015),
compared to non-footshock 3×Tg-AD mice. Footshock with
SRs also induced amyloid deposition, tau hyperphosphorylation,
and gliosis in the hippocampus and amygdala of 3×Tg-ADmice.
Aβ accumulation in the BLA contributes to increased anxiety
in AD transgenic mice (España et al., 2010; Lublin and Gandy,
2010). A strong correlation between microglia activation and
tau hyperphosphorylation has also been observed in previous
studies (Yoshiyama et al., 2007; Morales et al., 2013). Therefore,
behavioral dysfunction may provide insights regarding brain
responses to environmental risk factors such as footshock
with SRs.
Footshock with SRs exacerbated the progression of the
phenotype of 3×Tg-AD mice, as indicated by the impairment
of spatial learning and memory. Increases in gliosis, oxidative
stress, inflammation, and levels of Aβ, phosphorylated tau
protein, and BACE1 and a decrease in the pS9-GSK3β/GSK3β
ratio in the hippocampus were also observed in the 3×Tg-AD
mice. These results are consistent with recent evidence that
chronic mild stress accelerates the onset of AD phenotypes
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and pathological characteristics (Cuadrado-Tejedor and García-
Osta, 2016). Chronic stress results in reactive astrocytes, which
promote increased levels of BACE1 (Rossner et al., 2005).
Chronic stress, BACE1, and Aβ participate in a positive
feedback loop of amyloidogenesis to initiate and sustain
a stress response in neurons (O’Connor et al., 2008). Aβ
production may be a major connection between oxidative
stress and BACE1 (Tamagno et al., 2012). The levels of many
antioxidants are negatively regulated by the activity of GSK3β
(Farr et al., 2014). Furthermore, oxidative stress increases the
levels of phosphorylated tau protein, GSK3β, BACE1, and Aβ
in neurodegenerative diseases (Selvatici et al., 2013). Tau is
phosphorylated at many sites via several proline-directed protein
kinases, including GSK3β and CDK5 (Kimura et al., 2014).
However, in the present study, footshock increased the level of
GSK3β in 3×Tg-AD mice without interfering with the CDK5
signaling pathway (data not shown). This result is consistent
with a previous study that reported that chronic restraint stress
elevates GSK3β phosphorylation in mice (Kinoshita et al., 2012).
In this study, we also observed that footshock increased iNOS
but not COX2, NF-κB, or MAPK (data not shown) in 3×Tg-
AD mice. These data are consistent with a previous study
that suggested GSK3β activity promotes iNOS induction during
chronic inflammation (Cuzzocrea et al., 2006). Evidence also
suggests that iNOS enhances glial activation and cytokine release
(Diaz et al., 2014). Therefore, we suggest that the deficit in
hippocampus-dependent spatial learning and memory mediated
by footshock with SRs could be due to an increase in reactive
gliosis associated with oxidative stress and inflammation. This
deficit may be due to the increase in amyloidogenesis and
tau protein phosphorylation resulting from the increase in
hippocampal BACE1 levels and GSK3β activation.
Our results also indicate that reduced numbers of cholinergic
neurons in theMS/DB and noradrenergic neurons in the LCmay
significantly contribute to the pathogenesis of the phenotype of
footshock-stimulated 3×Tg-AD mice and that NaHS prevents
neuronal loss in these regions. A previous study in APP23 mice
indicated that norepinephrine depletion reduces the number
of cholinergic terminals (Heneka et al., 2006), and a meta-
analysis suggested that patients with AD might benefit from a
combination of cholinergic and noradrenergic therapy (Lyness
et al., 2003). Evidence also suggests that the loss of basal
forebrain cholinergic neurons promotes Aβ deposition and tau
hyperphosphorylation in the hippocampus in 3×Tg-AD mice
(Hartig et al., 2014). The behavioral response of an animal to
footshock challenges is dependent on the hippocampus and
is mediated by the LC and BLA (Lipski and Grace, 2013).
However, neither serotonergic neurons in the raphe nucleus nor
pyramidal neurons in the hippocampus differed between mice
under footshock or NaHS treatment. These results are consistent
with previous studies indicating that the number of serotonergic
neurons in the raphe nucleus is not altered by stress (Adamec
et al., 2012) and the absence of neuronal loss in the hippocampus
in a transgenic model of AD (Cuadrado-Tejedor et al., 2013).
Here, we suggest that footshock with SRs reduced the numbers
of cholinergic and noradrenergic neurons in association with
increased Aβ deposition and tau hyperphosphorylation in the
hippocampus; the semi-acute administration of NaHS prevented
these footshock-induced effects in 3×Tg-AD mice.
Furthermore, the administration of NaHS attenuated anxiety-
like behaviors and the deficit of spatial learning and memory
associated with increases in plasma H2S, antioxidation, anti-
inflammation, BACE1, and pS9-GSK3β as well as with decreases
in amyloid deposition, tau hyperphosphorylation, and reactive
gliosis in the footshock-stimulated 3×Tg-AD mice. Our finding
that NaHS treatment increased plasma H2S concentrations
and attenuated both emotional dysfunction and cognitive
impairment in the footshock-stimulated 3×Tg-AD mice is
consistent with the results of previous studies (Chen et al., 2013;
He et al., 2014). H2S exhibits strong antioxidant capacity and can
resist oxidative stress factors such as Aβ42 by reducing the BACE1
protein in LPS-induced abnormal pulmonary arteries (Zhang
et al., 2011). Hu et al. (2007) reported that the anti-inflammatory
effect of H2S against LPS-induced activation of microglia and
astrocytes was due to inhibition of the iNOS and p38-MAPK
signaling pathways in cell culture LPS-induced inflammation.
Previous studies have suggested that the administration of
NaHS ameliorates Aβ40-induced spatial learning and memory
impairment, apoptosis, and neuroinflammation at least in part
by inhibiting p38 MAPK and p65 NF-κB activity (Xuan et al.,
2012; Fan et al., 2013). However, NaHS treatment significantly
reduced the level of iNOS but not p38 MAPK or p65 NF-κB in
the footshock-stimulated AD mice.
In addition, synthesis of heat shock proteins (HSPs) can be
induced by stressful conditions, including heat shock, ischemia,
hypoxia, and heavy metals. Especially the substrates of Hsp90 are
well-known kinases that are responsible for the phosphorylation
of tau, such as GSK3β, CDK5, and Akt. Evidence also shows that
Hsp90 induced the production of cytokines, such as IL-6 or TNF-
α via both NF-κB and p38 MAPK pathways (Hwang et al., 2004).
Evidence further suggests that H2S-induced neuroprotection was
mediated by Hsp90 against chemical hypoxia-induced injury via
anti-oxidant and anti-apoptotic effects (Wuwongse et al., 2010).
In our in vivo study, the administration of NaHS decreased
the level of plasma IL-6 associated with a decrease in iNOS
expression, not both NF-κB and p38 MAPK pathways against
footshock stimulation. The NaHS treatment also increased
the level of activated GSK3β kinase, not CDK5 (data not
shown) against footshock stimulation. Therefore, further study of
Hsp90 in the NaHS-mediated neuroprotection against footshock
stimulationmight need a detailed evaluation to better understand
the disease pathogenesis and identify therapeutic targets for AD
in the future.
Evidence suggests that BACE1 expression was regulated
by GSK3β in AD pathogenesis (Ly et al., 2013). Moreover,
the amyloid and tau hypotheses are not mutually exclusive;
instead, amyloid and tau may concomitantly contribute to
neurodegeneration in AD (Ittner and Götz, 2011). In addition,
dual-target drugs that modulate both BACE1 and GSK3β
might represent a promising therapeutic strategy (Prati et al.,
2014). Furthermore, the inhibition of reactive gliosis is a
target for therapeutic interventions (Pekny et al., 2014).
Therefore, the semi-acute administration of NaHS may act as
a neurotherapeutic agent through multiple pathophysiological
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mechanisms, including antioxidative, anti-inflammatory, anti-
reactive gliosis, and reduce amyloid deposition and tau
hyperphosphorylation in the multifactorial pathogenesis of AD.
CONCLUSION
The present work demonstrated that footshock with SRs
induced anxiety-like behaviors and deficits in hippocampus-
dependent learning and memory involving pathological
changes in the peripheral and central system, including the
hippocampus, MS/DB, LC, and BLA regions. Moreover, multiple
pathophysiological processes were targeted and attenuated
by semi-acute treatment with NaHS in the 3×Tg-AD mice.
Therefore, we suggest that exogenous NaHS administration
may be a potential therapeutic strategy to alleviate the
multipathogenic presentation of AD.
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